From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications
Molecules · 2025
DOI: 10.3390/molecules30173650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Sayed H A Mohamed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt. Hauptthemen laut MEDLINE: Antioxidants, Antineoplastic Agents, Reishi, Depsides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fungi are a prolific source of diverse bioactive metabolites, yet many remain unexplored. Among these, depsidones are a rare class of compounds with significant biological potential, but they are seldom reported in mushrooms. This study investigated the medicinal fungus Ganoderma lucidum, known for its extensive therapeutic use in traditional medicine. Fruiting bodies were extracted using petroleum ether, ethyl acetate, n-butanol, and methanol. Extracts were screened phytochemically and assessed for total phenolic content and antioxidant activity using the DPPH assay. Ethyl acetate extract exhibited the highest phenolic yield and antioxidant potential and was subsequently evaluated for cytotoxicity against HepG2, HCT116, MCF7, and A549 cancer cell lines. It showed notable anticancer activity with minimal toxicity to normal Vero cells. UHPLC/Q-TOF-MS/MS analysis of G. lucidum ethyl acetate extract tentatively identified nine minor depsidones including mollicellin G, simplicildone I, mollicellin B, talaromyone B, simplicildone A, purpactin C, emeguisin B, mollicellin E, and simplicildone D on the basis of high-resolution negative-mode detection and characteristic MS/MS fragmentation patterns. Molecular docking revealed strong binding affinities between these compounds and cancer-related targets (AKT1, CDK2, ERK1, TNFα), with simplicildone D and mollicellin G demonstrating particularly high interactions. These findings provide mechanistic insights into the observed bioactivity and highlight G. lucidum as a promising source of therapeutic depsidones for future anticancer drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt.
- The Regional Center for Mycology and Biotechnology, Al-Azhar University, Nasr City, Cairo 11787, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
- Department of Molecular Genetics, Faculty of Biology, Technical University of Kaiserslautern, Paul-Ehrlich Str. 24, 67663 Kaiserslautern, Germany.
- Department of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
ORCID-Profile: Yehia A-G Mahmoud, Mohammed Yosri, Kamel Metwally, Galal Yahya, Mervt Almostafa
Zitieren
APA
Mohamed, S. H. A., Mahmoud, Y. A., Bediway, M. Y., Elsilk, S. E., Yosri, M., Metwally, K., Abo-Dya, N. E., Yahya, G., Almostafa, M., & El-Hela, A. A. (2025). From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications. Molecules. https://doi.org/10.3390/molecules30173650
Vancouver
Mohamed SHA, Mahmoud YA, Bediway MY, Elsilk SE, Yosri M, Metwally K, et al. From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications. Molecules. 2025. doi:10.3390/molecules30173650
BibTeX
@article{Mohamed2025,
author = {Mohamed, Sayed H A and Mahmoud, Yehia A-G and Bediway, Mohamed Y and Elsilk, Sobhy E and Yosri, Mohammed and Metwally, Kamel and Abo-Dya, Nader E and Yahya, Galal and Almostafa, Mervt and El-Hela, Atef A},
title = {From Mushrooms to Molecules: Exploring Depsidones in Ganoderma lucidum for Antioxidant and Anticancer Applications},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30173650}
}
EUVIMED